Passer au contenu principal

Chemical Entities of Biological Interest Ontology (CHEBI)

Choisissez le vocabulaire dans lequel chercher

aligner
annoter
télécharger

Concept information

... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > aromatic compound > organic aromatic compound > heteroarene > monocyclic heteroarene > azole > diazole > pyrazoles > N-pyrazin-2-yl-N(2)-{1-[2-(1H-pyrazol-1-yl)phenyl]ethyl}glycinamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic aromatic compound > heteroarene > monocyclic heteroarene > azole > diazole > pyrazoles > N-pyrazin-2-yl-N(2)-{1-[2-(1H-pyrazol-1-yl)phenyl]ethyl}glycinamide
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic aromatic compound > heteroarene > monocyclic heteroarene > azole > diazole > pyrazoles > N-pyrazin-2-yl-N(2)-{1-[2-(1H-pyrazol-1-yl)phenyl]ethyl}glycinamide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic aromatic compound > heteroarene > monocyclic heteroarene > azole > diazole > pyrazoles > N-pyrazin-2-yl-N(2)-{1-[2-(1H-pyrazol-1-yl)phenyl]ethyl}glycinamide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > organic heterocyclic compound > heteroarene > monocyclic heteroarene > azole > diazole > pyrazoles > N-pyrazin-2-yl-N(2)-{1-[2-(1H-pyrazol-1-yl)phenyl]ethyl}glycinamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > heteroarene > monocyclic heteroarene > azole > diazole > pyrazoles > N-pyrazin-2-yl-N(2)-{1-[2-(1H-pyrazol-1-yl)phenyl]ethyl}glycinamide
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > heteroarene > monocyclic heteroarene > azole > diazole > pyrazoles > N-pyrazin-2-yl-N(2)-{1-[2-(1H-pyrazol-1-yl)phenyl]ethyl}glycinamide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > heteroarene > monocyclic heteroarene > azole > diazole > pyrazoles > N-pyrazin-2-yl-N(2)-{1-[2-(1H-pyrazol-1-yl)phenyl]ethyl}glycinamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organic heterocyclic compound > heteroarene > monocyclic heteroarene > azole > diazole > pyrazoles > N-pyrazin-2-yl-N(2)-{1-[2-(1H-pyrazol-1-yl)phenyl]ethyl}glycinamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > azole > diazole > pyrazoles > N-pyrazin-2-yl-N(2)-{1-[2-(1H-pyrazol-1-yl)phenyl]ethyl}glycinamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organonitrogen compound > organonitrogen heterocyclic compound > azole > diazole > pyrazoles > N-pyrazin-2-yl-N(2)-{1-[2-(1H-pyrazol-1-yl)phenyl]ethyl}glycinamide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > azole > diazole > pyrazoles > N-pyrazin-2-yl-N(2)-{1-[2-(1H-pyrazol-1-yl)phenyl]ethyl}glycinamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > azole > diazole > pyrazoles > N-pyrazin-2-yl-N(2)-{1-[2-(1H-pyrazol-1-yl)phenyl]ethyl}glycinamide
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > azole > diazole > pyrazoles > N-pyrazin-2-yl-N(2)-{1-[2-(1H-pyrazol-1-yl)phenyl]ethyl}glycinamide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > azole > diazole > pyrazoles > N-pyrazin-2-yl-N(2)-{1-[2-(1H-pyrazol-1-yl)phenyl]ethyl}glycinamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organic heterocyclic compound > organonitrogen heterocyclic compound > azole > diazole > pyrazoles > N-pyrazin-2-yl-N(2)-{1-[2-(1H-pyrazol-1-yl)phenyl]ethyl}glycinamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > carboxamide > secondary carboxamide > N-pyrazin-2-yl-N(2)-{1-[2-(1H-pyrazol-1-yl)phenyl]ethyl}glycinamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > carboxamide > secondary carboxamide > N-pyrazin-2-yl-N(2)-{1-[2-(1H-pyrazol-1-yl)phenyl]ethyl}glycinamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > carboxamide > secondary carboxamide > N-pyrazin-2-yl-N(2)-{1-[2-(1H-pyrazol-1-yl)phenyl]ethyl}glycinamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > carboxamide > secondary carboxamide > N-pyrazin-2-yl-N(2)-{1-[2-(1H-pyrazol-1-yl)phenyl]ethyl}glycinamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organonitrogen compound > carboxamide > secondary carboxamide > N-pyrazin-2-yl-N(2)-{1-[2-(1H-pyrazol-1-yl)phenyl]ethyl}glycinamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > carboxamide > secondary carboxamide > N-pyrazin-2-yl-N(2)-{1-[2-(1H-pyrazol-1-yl)phenyl]ethyl}glycinamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic amino compound > secondary amino compound > N-pyrazin-2-yl-N(2)-{1-[2-(1H-pyrazol-1-yl)phenyl]ethyl}glycinamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organic amino compound > secondary amino compound > N-pyrazin-2-yl-N(2)-{1-[2-(1H-pyrazol-1-yl)phenyl]ethyl}glycinamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organonitrogen compound > organic amino compound > secondary amino compound > N-pyrazin-2-yl-N(2)-{1-[2-(1H-pyrazol-1-yl)phenyl]ethyl}glycinamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > diazines > pyrazines > N-pyrazin-2-yl-N(2)-{1-[2-(1H-pyrazol-1-yl)phenyl]ethyl}glycinamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organonitrogen compound > organonitrogen heterocyclic compound > diazines > pyrazines > N-pyrazin-2-yl-N(2)-{1-[2-(1H-pyrazol-1-yl)phenyl]ethyl}glycinamide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > diazines > pyrazines > N-pyrazin-2-yl-N(2)-{1-[2-(1H-pyrazol-1-yl)phenyl]ethyl}glycinamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > diazines > pyrazines > N-pyrazin-2-yl-N(2)-{1-[2-(1H-pyrazol-1-yl)phenyl]ethyl}glycinamide
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > diazines > pyrazines > N-pyrazin-2-yl-N(2)-{1-[2-(1H-pyrazol-1-yl)phenyl]ethyl}glycinamide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > diazines > pyrazines > N-pyrazin-2-yl-N(2)-{1-[2-(1H-pyrazol-1-yl)phenyl]ethyl}glycinamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organic heterocyclic compound > organonitrogen heterocyclic compound > diazines > pyrazines > N-pyrazin-2-yl-N(2)-{1-[2-(1H-pyrazol-1-yl)phenyl]ethyl}glycinamide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > diazines > pyrazines > N-pyrazin-2-yl-N(2)-{1-[2-(1H-pyrazol-1-yl)phenyl]ethyl}glycinamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > diazines > pyrazines > N-pyrazin-2-yl-N(2)-{1-[2-(1H-pyrazol-1-yl)phenyl]ethyl}glycinamide
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > diazines > pyrazines > N-pyrazin-2-yl-N(2)-{1-[2-(1H-pyrazol-1-yl)phenyl]ethyl}glycinamide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > diazines > pyrazines > N-pyrazin-2-yl-N(2)-{1-[2-(1H-pyrazol-1-yl)phenyl]ethyl}glycinamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organic heterocyclic compound > organic heteromonocyclic compound > diazines > pyrazines > N-pyrazin-2-yl-N(2)-{1-[2-(1H-pyrazol-1-yl)phenyl]ethyl}glycinamide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > monocyclic compound > heteromonocyclic compound > organic heteromonocyclic compound > diazines > pyrazines > N-pyrazin-2-yl-N(2)-{1-[2-(1H-pyrazol-1-yl)phenyl]ethyl}glycinamide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > heteromonocyclic compound > organic heteromonocyclic compound > diazines > pyrazines > N-pyrazin-2-yl-N(2)-{1-[2-(1H-pyrazol-1-yl)phenyl]ethyl}glycinamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > amino acid derivative > proteinogenic amino acid derivative > glycine derivative > N-pyrazin-2-yl-N(2)-{1-[2-(1H-pyrazol-1-yl)phenyl]ethyl}glycinamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organonitrogen compound > amino acid derivative > proteinogenic amino acid derivative > glycine derivative > N-pyrazin-2-yl-N(2)-{1-[2-(1H-pyrazol-1-yl)phenyl]ethyl}glycinamide

Terme préférentiel

N-pyrazin-2-yl-N(2)-{1-[2-(1H-pyrazol-1-yl)phenyl]ethyl}glycinamide  

Concept générique

Appartient au groupe

URI

http://data.loterre.fr/ark:/67375/KFP-BBJRLRPJ-F

Télécharger ce concept :

RDF/XML TURTLE JSON-LD